Volume : 12, Issue : 09, September – 2025

Title:

FORMULATION DESIGN AND IN VITRO EVALUATION OF EPLERENONE GASTRORETENTIVE FLOATING MATRIX TABLETS FOR THE MANAGEMENT OF HYPERTENSION

Authors :

Mahek Erum, Uneza Naaz, Asfiyan Uddin Khan, Sameena Begum*

Abstract :

This study aimed to design and assess a hydrodynamically balanced floating matrix-controlled drug delivery system for Eplerenone. The elimination half-life of Eplerenone ranges from 3 to 6 hours. The gastric buoyancy of Eplerenone tablets is due to the effervescence generated by the reaction between sodium bicarbonate and hydrochloric acid in the stomach. Twelve distinct formulations of floating tablets were developed utilizing the direct compression method with hydrophilic polymers, including HPMC K4M, K15M, and K100M, alongside hydrophobic polymers such as Eudragit RSPO, in diverse ratios. The characterisation of the formulated preparation was conducted utilizing FTIR and DSC analyses. The evaluation results indicated that all formulations adhere to the specifications of official pharmacopoeias and/or standard references regarding general appearance, content consistency, hardness, friability, and buoyancy. Among all the formulations created, formulation EFT10, which comprises 25% HPMC K100M and 12.5% eudragit RSPO, demonstrated optimal in vitro drug release, achieving 99% at the conclusion of 12 hours. Formulations containing above 12.5% NaHCO3 exhibited a floating duration exceeding 12 hours. The kinetics of in vitro drug release for the improved formulation EFT10 exhibited zero-order kinetics, with a drug release mechanism characterized by anomalous diffusion combined with erosion. Accelerated stability experiments were conducted, revealing little alteration in physicochemical attributes and drug release profiles after 90 days, showing that all formulations remained stable.
Key words: Gastroretensive drug delivery, floating drug delivery, Eplerenone, Eudragit RSPO, HPMC K4M, K15M, K100M

Cite This Article:

Please cite this article in press Sameena Begum et al., Formulation Design And In Vitro Evaluation Of Eplerenone Gastroretentive Floating Matrix Tablets For The Management Of Hypertension., Indo Am. J. P. Sci, 2025; 12(09).

REFERENCES:

1. AV Mayavanshi and SS Gajjar. Floating drug delivery systems to increase gastric retention of drugs: A Review. Research J. Pharm. and Tech. 2008; 1(4):345-348.
2. Nagendra R. , Divyashree P. , Venkatesh K. , Hanumanthachar Joshi, Nanditha V. V. , Floating Drug Delivery System: A Review, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 2, 164-175. https://doi.org/10.5281/zenodo.10628440.
3. Naish J, Court DS, Medical sciences (2nd ed.). Elsevier Health Sciences. (2014). p. 562. ISBN 978-0-7020-5249-1.
4. “Hypertension”. World Health Organization (WHO). 16 March 2023. Retrieved 22 May 2024.
5. Tam T.S., Wu M.H., Masson S.C., Tsang M.P., Stabler S.N., Kinkade A., Tung A., Tejani A.M. Eplerenone for hypertension. Cochrane Database Syst. Rev. 2017;2:CD008996.
6. Mohammad Abuanna, and James H. O’Keefe, Review Article: Eplerenone: An Underused Medication?, Journal of Cardiovascular Pharmacology and Therapeutics 15(4):318-25
7. Pathuri et al, Conceptuation, formulation and evaluation of sustained release floating tablets of captopril compression coated with gastric dispersible hydrochlorothiazide using 23 factorial design; Int. J. of Pharma. Invest., 2014, Vol 4, Issue 2, 77-87.
8. Vinay Dhananjay Gaikwad, Vishal Dadasaheb Yadav, Manish Dhananjay Gaikwad, Novel sustained release and swellable gastroretentive dosage form for ciprofloxacin hydrochloride, Int. J. of Pharma. Invest., 2014, Vol 4, Issue 2, 88-92.
9. S.Katyayini and Sellappan Velmurugan; Formulation and Evaluation of Effervescent Floating Tablets of Losartan, Int. J Of Pharm And Pharma Sc. Int J Pharm Pharm Sci, 2013, Vol 5, Issue 3, 559-565.
10. Sundar et al, Formulation and evaluation of floating matrix tablets of clarithromycin using different grades of HPMC, Int J Pharm Pharm Sci, 2013, Vol 5, Issue 3, 174-176.
11. Zafar R and Panda N: Formulation Design and In Vitro Evaluation of Zolmitriptan Gastroretensive Floating Matrix Tablets For Management of Migraine. Int J Pharm Sci Res 2015; 6(9): 3901-12.doi: 10.13040/IJPSR.0975-8232.6(9).3901-12.
12. Prajapati, et al, Formulation and evaluation of floating matrix tablet of stavudine, Int J of Pharma Invest, Vol 2, Issue 2, 2012, 83-89.
13. Chen, Y.C., Ho, H.O., Lee, T.Y., Sheu, M.T., Physical characterizations and sustained release profiling of gastroretentive drug delivery systems with improved floating and swelling capabilities. Int. J. Pharm. 441, 2013, 162–169.
14. S.P.Vyas, R.K.Khar, gastroretentive system, controlled drug delivery concept and advancement, 2nd edition, 2002; 196-213.
15. Niranjan, P.; Reddy, A.V.; Reddy, G.V.S.; Panda, K.C. Formulation, design and in vitro evaluation of zolmitriptan immediate release tablets using Primojel and Ac-Di-Sol. J. Pharm. Sci. Res. 2015, 7, 545–553.
16. Niranjan Panda et al., Formulation And Evaluation Of Buccal Mucoadhesive Tablet Of Dalfampridine, Indo Am. J. P. Sci, 2025; 12 (02).
17. Yin, L., Qin, C., Chen, K., Zhu, C., Cao, H., Zhou, J., He, W., Zhang, Q.,Gastro-floating tablets of cephalexin: preparation and in vitro/in vivo evaluation. Int. J. Pharm. 452, 2013. 241–248.
18. Fatima S, Panda N, Reddy AV, Fatima S. Buccal mucoadhesive tablets of sumatriptan succinate for treatment of sustainable migraine: Design, formulation and in-vitro evaluation. Int. J. Pharm. Res. Allied Sci. 2015;4:114–26.
19. Sungthongjeen, S., Sriamornsak, P., Puttipipatkhachorn, S., Design and evaluation of floating multi-layer coated tablets based on gas formation. Eur. J. Pharm. Biopharm. 69, 2008, 255–263.
20. Panda N, Charan Panda K, Reddy AV, Reddy GVS. Process optimization, formulation and evaluation of hydrogel {guar gum-g-poly(acrylamide)} based doxofylline microbeads. Asian J Pharm Clin Res. 2014 Jul 1;7(3):60-5.
21. Panda N, Reddy AV, Reddy GV, Sultana A. Formulation design and in vitro evaluation of bilayer sustained release matrix tablets of doxofylline. Int J Pharm Pharm Sci. 2015;7(10):74–83.
22. Akbar M, Panda N, Reddy AV.Formulation and evaluation of doxofylline sublingual tablets using sodium starch glycolate and crosscarmellose sodium as superdisintegrant. Int. j. pharm. res. allied sci 2015; 4(2):90-100.
23. Ramesh Bomma, Rongala Appala Awamy Naidu, Madhusudan Rao Yamsani, Kishan Veerabrahma. Development and evaluation of Gastroretentive Norfloxacin floating tablets. Acta Pharm 2009; 59:211–221.
24. Panda N, Reddy AV, Reddy GVS, Sultana A. Formulation design and in vitro evaluation of bilayer sustained release matrix tablets of doxofylline. Int J Pharm Pharm Sci 2015;7:74-83.
25. N Anjali Devi, Mohd Abdul Hadi, P Rajitha, Jvc Sharma, A Srinivasa Rao, Formulation and Evaluation of Floating Controlled Release Tablets of Imatinib Mesylate Using Hydrophilic Matrix System; Int J Pharm Pharm Sci, 2012, Vol 5, Issue 1, 271-277.
26. Panda N, Sultana A, Reddy AV, Reddy GVS and Ansari MS. Formulation Design and Study the effect of Polyplasdone-XL and AC-Di-Sol on Release Profile of Doxofylline Immediate Release Tablets. International Journal of Pharmaceutical Sciences Review & Research 2015; 32: 67- 76.
27. Niranjan Panda; Vurathi Sreenivasulu, Vakkalagadda Ravi Kumar, V.Kiran Kumar, L.Rajesh Patro, P. Sobitha Rani, Formulation Design and Characterization of Pitavastatin Calcium Lipid-Based Solid Self-Emulsifying Delivery System, Journal of Clinical Otorhinolaryngology, Head, and Neck Surgery, 27 (1), 2023. 998-1008.
28. SA Ahmed, N Panda, MS Ansari, A Kauser, Development and in vitro evaluation of acebrophylline sustained release matrix tablets employing different grade of HPMC and ethyl cellulose, J. Glob. Trends Pharm. Sci, 6 (2015), 2716-2727.